Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom

被引:45
作者
Langman, M
Kahler, KAH
Kong, SX
Zhang, QY
Finch, E
Bentkover, JD
Stewart, EJ
机构
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Merck & Co Inc, Whitehouse Stn, NJ USA
[3] Innovat Hlth Solut, Brookline, MA USA
关键词
anti-inflammatory agents; non-steroidal; switching; drug utilization;
D O I
10.1002/pds.653
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To examine the frequency and determinants of switching between different non-steroidal anti-inflammatory drugs (NSAIDs) and the relationship with co-prescription of gastro-protective drugs (GPDs). Design This was an analysis of 30 654 patients receiving a total of 209 140 NSAID prescriptions in the UK from 1 January 1997 to 31 December 1998 identified through the MediPlus database. Analyses examined switching, repeat, termination and GPD co-prescription rates in new and continuing takers according to age and sex. Results Each patient received an average of 6.8 prescriptions in the year of study. Of the prescriptions 72.2% were for one of three NSAIDs, ibuprofen, diclofenac, or naproxen, and 7.2% of prescriptions were for fixed combination products of an NSAID plus a gastroprotective drug. At least 16.0% of continuing takers, and 28.5% of new takers switched to another NSAID in the review period. On average, new patients switched more frequently than continuing patients (0.39 switches/patient/year versus 0.23 switches/patient/year, p<0.001). Switching between NSAIDs decreased with age and was less common in women (p<0.05). Switching was associated with a 24% and 33% increased probability of GPD prescription in new and continuing takers, respectively. Discussion The frequency of switching, and of GPD co-prescription at switching, suggest that dissatisfaction with NSAIDs is frequent, and that gastrointestinal intolerance is a common feature of this dissatisfaction. Copyright (C) 2001 John Wiley Sons, Ltd.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 23 条
[11]   Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study [J].
MacDonald, TM ;
Morant, SV ;
Robinson, GC ;
Shield, MJ ;
McGilchrist, MM ;
Murray, FE ;
McDevitt, DG .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7119) :1333-1337
[12]   NSAIDs and the elderly - Toxicity and economic implications [J].
Phillips, AC ;
Polisson, RP ;
Simon, LS .
DRUGS & AGING, 1997, 10 (02) :119-130
[13]   Nonsteroidal anti-inflammatory drugs: Practical and theoretical considerations in their selection [J].
Polisson, R .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 :S31-S36
[14]   Cost of prescribed NSAID-related gastrointestinal adverse events in elderly patients [J].
Rahme, E ;
Joseph, L ;
Kong, SX ;
Watson, DJ ;
LeLorier, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (02) :185-192
[15]   Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs [J].
Rodríguez, LAG ;
Cattaruzzi, C ;
Troncon, MG ;
Agostinis, L .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (01) :33-39
[16]  
ROSTOM A, 2001, COCHRANE LIB
[17]  
Saint-Yves I F, 1992, Health Bull (Edinb), V50, P422
[18]  
*SAS I INC, 1990, VERS 6
[19]   MISOPROSTOL REDUCES SERIOUS GASTROINTESTINAL COMPLICATIONS IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
SILVERSTEIN, FE ;
GRAHAM, DY ;
SENIOR, JR ;
DAVIES, HW ;
STRUTHERS, BJ ;
BITTMAN, RM ;
GEIS, GS .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (04) :241-249
[20]   Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis - A prospective observational cohort study [J].
Singh, G ;
Ramey, DR ;
Morfeld, D ;
Shi, H ;
Hatoum, HT ;
Fries, JF .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (14) :1530-1536